Back to Search
DR. JOHN ERIC BARTSCH MD
MD
Physical Medicine & Rehabilitation Physician
NPI: 1326255043IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
35092025(OH)
Education
MEDICAL COLLEGE OF OHIO
Class of 2005
Research & Publications (20)
Adhesion and migration of extracellular matrix-stimulated breast cancer.
PMID 12697413·J Surg Res·2003
8-other
ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.
PMID 19601829·Curr Pharm Des·2009
6-review
A swine model of pseudo-pulseless electrical activity induced by partial asphyxiation.
PMID 18502560·Resuscitation·2008
7-preclinical
Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
PMID 18287572·Biol Reprod·2008
7-preclinical
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.
PMID 17895248·J Biol Chem·2007
7-preclinical
Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
PMID 16772875·J Neuropathol Exp Neurol·2006
4-observational
SH3P7/mAbp1 deficiency leads to tissue and behavioral abnormalities and impaired vesicle transport.
PMID 16601697·EMBO J·2006
7-preclinical
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
PMID 16542157·Biol Chem·2006
8-other
ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
PMID 16206338·J Rheumatol·2005
8-other
Focal cerebral ischemia induces changes in both MMP-13 and aggrecan around individual neurons.
PMID 16112096·Brain Res·2005
4-observational
Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.
PMID 15580619·Dev Dyn·2005
7-preclinical
An investigation of liquid carryover and sample residual for a high-throughput flow cytometer sample delivery system.
PMID 15228359·Anal Chem·2004
8-other
Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death.
PMID 14761956·J Biol Chem·2004
7-preclinical
Transcriptional regulation of cytosol and membrane alanyl-aminopeptidase in human T cell subsets.
PMID 12751795·Biol Chem·2003
8-other
The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.
PMID 12372841·J Biol Chem·2002
7-preclinical
Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2.
PMID 12009762·Exp Neurol·2002
7-preclinical
Genetic modifiers that aggravate the neurological phenotype of the wobbler mouse.
PMID 11930176·Neuroreport·2002
7-preclinical
Conditional cell ablation by stringent tetracycline-dependent regulation of barnase in mammalian cells.
PMID 11504884·Nucleic Acids Res·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 E BUSINESS WAY, SUITE A
CINCINNATI, OH 45241 - Phone
- (513) 354-3700
Quick Facts
- NPI
- 1326255043
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile